Durability of immune responses to the BNT162b2 mRNA vaccine
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.09.30.462488: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Human subjects and experimentation: Fifty-six healthy volunteers were recruited for the study at the Stanford University under informed consent.
IRB: The study was approved by Stanford University under Institutional Review Board protocols 8269 and 60171.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Cells were incubated with an anti-SARS-CoV spike primary antibody directly conjugated with alexaflour-647 (CR3022-AF647) for up to 4 hours at room temperature. anti-SARS-CoV spikesuggested: NoneExperimental Models: Cell Lines Sentences Resources SciScore for 10.1101/2021.09.30.462488: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Human subjects and experimentation: Fifty-six healthy volunteers were recruited for the study at the Stanford University under informed consent.
IRB: The study was approved by Stanford University under Institutional Review Board protocols 8269 and 60171.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Cells were incubated with an anti-SARS-CoV spike primary antibody directly conjugated with alexaflour-647 (CR3022-AF647) for up to 4 hours at room temperature. anti-SARS-CoV spikesuggested: NoneExperimental Models: Cell Lines Sentences Resources The hCoV-19/Japan/TY7-503/2021 (P.1) was provided by BEI resources and propagated in Vero-TMPRSS2 cells. Vero-TMPRSS2suggested: JCRB Cat# JCRB1818, RRID:CVCL_YQ48)The antibody-virus mixture was then added to VeroE6-TMPRSS2 cells and incubated at 37° C for 1 hour. VeroE6-TMPRSS2suggested: JCRB Cat# JCRB1819, RRID:CVCL_YQ49)Software and Algorithms Sentences Resources hCoV-19/USA/CA-Stanford-15_S02/2021 (herein referred to as the B.1.617.1 variant) was derived from a mid-turbinate nasal swab collected from a Stanford Healthcare patient in March 2021 and isolated as previously described16. Stanford Healthcaresuggested: NoneThe FRNT-50 titers were interpolated using a 4-parameter nonlinear regression in GraphPad Prism 8.4.3. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)All flow cytometry data were analysed using Flowjo software v.10 (TreeStar). Flowjosuggested: (FlowJo, RRID:SCR_008520)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT04828603 Recruiting Understanding Allergies and Sensitizations in Healthy and Al… NCT04664309 Recruiting Understanding Immunity to the COVID-19 Vaccines Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
